{"slideshow_credits": null, "snippet": "Joel Schwartz, a reader, suggests that the anti-inflammatory drug should be discussed in the context of performance-enhancing drugs.", "abstract": null, "section_name": "Opinion", "print_page": "34", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2014/12/05/opinion/old-guys-drug-advil.html", "lead_paragraph": "Joel Schwartz, a reader, suggests that the anti-inflammatory drug should be discussed in the context of performance-enhancing drugs.", "headline": {"main": "Old Guys&#8217; Drug: Advil", "print_headline": "Old Guys\u2019 Drug: Advil", "content_kicker": "Letter", "kicker": "Letter"}, "_id": "5480f37e38f0d874625c7d05", "word_count": "101", "multimedia": [], "pub_date": "2014-12-05T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"value": "Steroids", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Athletics and Sports", "name": "subject", "is_major": "N", "rank": "2"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}